2Matulionyte R,Rohner P,Uckay I,et al.Secular trends of nocardia infection over 15 years in a tertiary care hospital[J].J Clin Pathol,2004,57(8):807-812.
3Shimamoto H,Inaba Y,Yamaura H,et al.Chest wall dissemination of nocardiosis after percutaneous transthoracic needle biopsy[J].Cardiovasc Intervent Radiol,2007,30(4):797-799.
4Munoz J,Mirelis B,Aragon LM,et al.Clinical and microbiological features of nocardiosis 1997-2003[J].J Med Microbiol,2007,56(Pt 4):545-550.
5Pintado V,Gomez-Mampaso E,Fortun J,et al.Infection with Nocardia speci-es:clinical spectrum of disease and species distribution in Madrid,Spain,1978-2001[J].Infection,2002,30(6):338-340.
6Martinez Tomas R,Menendez Villanueva R,Reyes Calzada S,et al.Pulmonary nocardiosis:risk factors and outcomes[J].Respirology,2007,12(3):394-400.
7Brown-Elliott BA,Ward SC,Crist CJ,et al.In vitro activities of linezolid against multiple Nocardia species[J].Antimicrob Agents Chemother,2001,45(4):1295-1297.
9McNeil MM, Brown JM. The medically important aerobic acti- nomycetes: epidemiology and microbiology [J]. Clin Microbiol Rev, 1994, 7, 7(3): 357-417. DOI: 10.1128/CMR. 7.3.357.
10Beaman BI., Burnside J, Edwards B, et al. Nocardial infections in the United States, 1972-1974[J]. J Infect Dis, 1976, 134(3): 286-289. DOI: 10.1093/infdis/134. 3. 286.
